Related Experiment Video

Updated: Aug 7, 2026

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
12:19

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks

Published on: November 10, 2016

The beta-carboline analog Mana-Hox causes mitotic aberration by interacting with DNA

Lan Chun Tu1, Chien-Shu Chen, I-Ching Hsiao

  • 1Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan.

Chemistry & Biology
|December 17, 2005
PubMed

Insights

Mana-Hox, an anticancer beta-carboline analog, targets DNA and disrupts mitosis by inhibiting topoisomerase II. This DNA binding is critical for its observed anticancer effects and aberrant mitosis induction.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Mana-Hox, a beta-carboline analog, exhibits anticancer properties by inducing aberrant mitosis.
  • The precise cellular target and mechanism of action for Mana-Hox remain unidentified.

Purpose of the Study:

  • To investigate the intracellular localization and molecular target of Mana-Hox.
  • To elucidate the mechanism by which Mana-Hox induces aberrant mitosis and exerts anticancer activity.

Main Methods:

  • Cellular uptake and localization studies using microscopy.
  • In vitro assays to assess DNA binding (intercalation, minor groove binding) and topoisomerase II inhibition.

Main Results:

  • Mana-Hox rapidly enters cells and accumulates on disorganized metaphase chromosomes.
  • Mana-Hox functions as a noncovalent DNA binder.
  • Mana-Hox inhibits the relaxation activity of topoisomerase II in vitro.

Conclusions:

  • Mana-Hox binds to DNA, potentially through intercalation or minor groove interactions.
  • Inhibition of topoisomerase II by Mana-Hox likely perturbs mitotic chromosome decatenation.
  • Mana-Hox's DNA binding is a key factor in its ability to induce aberrant mitosis and contribute to its anticancer efficacy.

More Related Videos

An Array-based Comparative Genomic Hybridization Platform for Efficient Detection of Copy Number Variations in Fast Neutron-induced Medicago truncatula Mutants09:32

An Array-based Comparative Genomic Hybridization Platform for Efficient Detection of Copy Number Variations in Fast Neutron-induced Medicago truncatula Mutants

Published on: November 8, 2017

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...